TAFSURE (tenofovir alafenamide) works by inhibiting reverse transcriptase, a key enzyme needed for viral replication, thereby reducing HIV and HBV viral loads.
Recommended for:
HIV-1 infection as part of antiretroviral combination therapy in adults and adolescents
Chronic hepatitis B in patients with compensated liver function
Patients switching from tenofovir disoproxil due to renal or bone-related side effects
HIV-1 infection
Chronic hepatitis B
Take orally once daily with or without food. Should be used as part of a prescribed combination regimen under medical supervision.
Contraindications:
Hypersensitivity to tenofovir
Severe hepatic impairment
Under 12 years of age
Use with nephrotoxic agents
Side Effects:
Nausea, headache
Elevated liver enzymes
Decreased bone mineral density
Increased serum creatinine
Rash, fatigue